Bayer AG
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
56/100
Moderate Influence
$10.2M
Total Lobby Spend
5
Policy Issues
4
Lobbyists
1
Revolving Door
Bayer AG reported $10.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Agriculture. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Commerce
Environmental Protection Agency
Dept of Health & Human Services
US Senate
Dept of State
Dept of Defense
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | K&L Gates LLP | HCRENV | 2 | $366K |
| 2020 Apr-Jun | Brownstein Hyatt LLP | ENV | 3 | $483K |
| 2020 Jul-Sep | K&L Gates LLP | PHAHCRENV+1 | 4 | $288K |
| 2020 Oct-Dec | Holland & Knight LLP | HCRGOVENV+2 | 3 | $286K |
| 2021 Jan-Mar | Cassidy & Associates LLP | AGRGOVENV+2 | 4 | $551K |
| 2021 Apr-Jun | Cassidy & Associates LLP | PHAENVAGR | 2 | $730K |
| 2021 Jul-Sep | Squire Patton Boggs LLP | GOVENV | 3 | $423K |
| 2021 Oct-Dec | Cassidy & Associates LLP | PHAENVAGR+2 | 2 | $595K |